- Home
- ARGX vs DB Comparison
ARGX vs DB Comparison
Compare ARGX & DB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- DB
- Stock Information
- Founded
- ARGX 2008
- DB 1870
- Country
- ARGX Netherlands
- DB Germany
- Employees
- ARGX N/A
- DB N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- DB Major Banks
- Sector
- ARGX Health Care
- DB Finance
- Exchange
- ARGX Nasdaq
- DB Nasdaq
- Market Cap
- ARGX 35.2B
- DB 33.6B
- IPO Year
- ARGX 2017
- DB N/A
- Fundamental
- Price
- ARGX $589.51
- DB $16.81
- Analyst Decision
- ARGX Strong Buy
- DB Buy
- Analyst Count
- ARGX 21
- DB 2
- Target Price
- ARGX $619.79
- DB N/A
- AVG Volume (30 Days)
- ARGX 302.1K
- DB 1.8M
- Earning Date
- ARGX 10-31-2024
- DB 10-23-2024
- Dividend Yield
- ARGX N/A
- DB 2.92%
- EPS Growth
- ARGX N/A
- DB N/A
- EPS
- ARGX N/A
- DB 2.11
- Revenue
- ARGX $1,908,659,000.00
- DB $30,817,532,890.00
- Revenue This Year
- ARGX $61.99
- DB N/A
- Revenue Next Year
- ARGX $42.48
- DB $3.26
- P/E Ratio
- ARGX N/A
- DB $7.55
- Revenue Growth
- ARGX 85.56
- DB 1.70
- 52 Week Low
- ARGX $327.73
- DB $12.05
- 52 Week High
- ARGX $611.22
- DB $17.95
- Technical
- Relative Strength Index (RSI)
- ARGX 56.12
- DB 45.80
- Support Level
- ARGX $558.15
- DB $16.58
- Resistance Level
- ARGX $592.29
- DB $16.89
- Average True Range (ATR)
- ARGX 12.42
- DB 0.22
- MACD
- ARGX -2.11
- DB -0.03
- Stochastic Oscillator
- ARGX 56.76
- DB 36.02
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
About DB Deutsche Bank AG
Deutsche Bank is a universal bank operating on a global scale. The bank offers corporate, retail, investment banking, private banking, and asset management to its clients.